Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| Buy TATA POWER for Target Price Of Rs. 170: Edelweiss | |
| Company: | Tata Power |
| Brokerage: | Edelweiss |
| Date of report: | August 5, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 29% |
| Summary: | The Shift: Changing business orientation |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Edelweiss, Tata Power |
| Devyani International IPO Review By ICICI-Direct | |
| Company: | Devyani International |
| Brokerage: | ICICI-Direct |
| Date of report: | August 4, 2021 |
| Type of Report: | Techno-Funda |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Biggest franchise of KFC in India |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Devyani International, ICICI-Direct, IPO |
| Buy HDFC Ltd for target price of Rs. 3100 (26% upside): ICICI-Direct | |
| Company: | HDFC |
| Brokerage: | ICICI-Direct |
| Date of report: | August 2, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | Steady operations; business to pick up from here on… |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HDFC, ICICI Securities |
| Great opportunity to accumulate Concor stock: Edelweiss | |
| Company: | CONCOR |
| Brokerage: | Edelweiss |
| Date of report: | July 30, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 24% |
| Summary: | Gaining traction as pieces fall in place |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Concor, Edelweiss |
| NOCIL is a net cash company with strong corporate governance track record: SMIFS | |
| Company: | NOCIL |
| Brokerage: | Stewart & Mackertich |
| Date of report: | July 26, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 16% |
| Summary: | Healthy double-digit volume growth on the cards |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | NOCIL, Stewart & Mackertich |
| Laurus Labs has strong order book visibility, improving margin profile & strengthening return ratios: ICICI Direct | |
| Company: | Laurus Labs |
| Brokerage: | ICICI-Direct |
| Date of report: | July 30, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 24% |
| Summary: | Strong performance driven by formulations… |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI-Direct, Laurus Labs |
| UltraTech Cement has Market leadership, strong brand with highest retail presence and robust balance sheet: ICICI-Direct | |
| Company: | Ultratech Cement |
| Brokerage: | ICICI-Direct |
| Date of report: | July 23, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Margin stays firm; outlook remains healthy… |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI-Direct, Ultratech Cement |
| Gandhi Special Tubes has a history of rewarding shareholders with healthy dividends and buybacks: ICICI-Direct | |
| Company: | Gandhi Special Tubes |
| Brokerage: | ICICI-Direct |
| Date of report: | July 24, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 16% |
| Summary: | Encouraging growth prospects lie ahead… |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Gandhi Special Tubes, ICICI-Direct |
| Glenmark Life Sciences Ltd IPO Review By ICICI-Direct | |
| Company: | Glenmark Life Sciences Ltd |
| Brokerage: | ICICI-Direct |
| Date of report: | July 23, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Leadership in select APIs, strong relation with large companies |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Glenmark Life Sciences Ltd, ICICI-Direct, IPO |